MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 73 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,096,444 | +279.5% | 224,571 | +210.7% | 0.00% | +100.0% |
| Q2 2023 | $1,869,987 | +47.6% | 72,284 | +37.1% | 0.00% | – |
| Q1 2023 | $1,266,791 | +25.5% | 52,739 | +1.8% | 0.00% | – |
| Q4 2022 | $1,009,769 | -4.6% | 51,783 | +2.8% | 0.00% | – |
| Q3 2022 | $1,058,000 | +27.8% | 50,353 | +18.4% | 0.00% | – |
| Q2 2022 | $828,000 | +142.1% | 42,511 | +174.3% | 0.00% | – |
| Q1 2022 | $342,000 | +45.5% | 15,500 | +5.5% | 0.00% | – |
| Q4 2021 | $235,000 | -19.8% | 14,696 | 0.0% | 0.00% | – |
| Q3 2021 | $293,000 | -77.5% | 14,696 | -80.5% | 0.00% | – |
| Q2 2021 | $1,304,000 | -13.8% | 75,418 | -1.2% | 0.00% | -100.0% |
| Q1 2021 | $1,513,000 | +45.5% | 76,317 | +28.1% | 0.00% | – |
| Q4 2020 | $1,040,000 | -7.8% | 59,553 | +1.8% | 0.00% | -100.0% |
| Q3 2020 | $1,128,000 | +277.3% | 58,487 | +281.4% | 0.00% | – |
| Q2 2020 | $299,000 | +91.7% | 15,333 | +38.4% | 0.00% | – |
| Q1 2020 | $156,000 | – | 11,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |